title: Effects of pioglitazone on stearoyl-CoA desaturase in obese Zucker fa/fa rats.
abstract: The effects of a peroxisome proliferator activated receptor gamma (PPARgamma) agonist on hepatic stearoyl-CoA desaturase (SCD) in insulin-resistant and obese Zucker fa/fa rats were studied. The administration of pioglitazone, a PPARgamma agonist, to Zucker obese rats greatly improved their insulin sensitivity. The treatment of Zucker obese rats with pioglitazone did not affect the index of fatty acid desaturation of either serum or liver. Hepatic SCD activity and the mRNA level of SCD1 were not changed by treatment of the rats with pioglitazone. The activity of palmitoly-CoA chain elongase, which is involved in the biosynthesis of oleic acid in concert with SCD, was not significantly altered when Zucker obese rats received pioglitazone. Although neither the activity nor mRNA expression of acyl-CoA oxidase was changed by treatment of Zucker obese rats with pioglitazone, the mRNA expressions of both sterol regulatory element-binding protein-1c and acetyl-CoA carboxylase sensitively responded to the challenge by pioglitazone. These results suggest that the insulin sensitivity of insulin-resistant and obese Zucker fa/fa rats is improved by pioglitazone independently of SCD activity.
authors.affiliation: Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan.
authors.forename: Tomoaki
authors.initials: T
authors.lastname: Toyama
authors.forename: Naomi
authors.initials: N
authors.lastname: Kudo
authors.forename: Yasuhide
authors.initials: Y
authors.lastname: Hibino
authors.forename: Atsushi
authors.initials: A
authors.lastname: Mitsumoto
authors.forename: Masazumi
authors.initials: M
authors.lastname: Nishikawa
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Kawashima
mesh_terms: D042962:Acyl-CoA Oxidase / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose; D005227:Fatty Acids / Q000378:metabolism; D015870:Gene Expression; D005951:Glucose Tolerance Test; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009765:Obesity; D019301:Oleic Acid / Q000096:biosynthesis; D047495:PPAR gamma / Q000819:agonists*; D010171:Palmitoyl Coenzyme A / Q000378:metabolism; D000077205:Pioglitazone; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D011924:Rats, Zucker; D013230:Stearoyl-CoA Desaturase / Q000187:drug effects* / Q000378:metabolism; D045162:Thiazolidinediones / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D005227:Fatty Acids; D007004:Hypoglycemic Agents; D007328:Insulin; D047495:PPAR gamma; D012333:RNA, Messenger; D045162:Thiazolidinediones; D010171:Palmitoyl Coenzyme A; D019301:Oleic Acid; D013230:Stearoyl-CoA Desaturase; D042962:Acyl-CoA Oxidase; D000077205:Pioglitazone